The group had formerly claimed that the AstraZeneca-Oxford jab, which also causes deadly blood clots, is far more beneficial than it is dangerous. Now, the EMA is backtracking a bit as it concerns the J&J jab, which is likewise dangerous for the very same reason.
Even though the risk of developing deadly blood clots post-injection is said to be "very rare," enough people are dying that the government can no longer ignore the issue or try to sweep it under the rug. Instead, health authorities will quietly label the injections as dangerous and hope people still agree to get them.
The EMA is not, however, planning to put the same warning label on the AstraZeneca jab, probably because that one is made in Europe and the J&J one is made in the United States.
The EMA's safety committee, known as PRAC, determined that blood clots caused by the vaccine occur at unusual sites such as in the veins of the brain (cerebral venous sinus thrombosis, CVST) and in the abdomen (splanchnic vein thrombosis), as well as in the arteries. These blood clots are typically accompanied by low levels of blood platelets and occasional bleeding.
The committee found that these deadly adverse effects are similar to the ones that occur post-injection with the AstraZeneca-Oxford jab. But again, that one is not being restricted because Europe is relying on it to get most people on the continent injected.
In a statement, the committee warned that healthcare professionals and others who receive the injection "should be aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within three weeks of vaccination."
A top official from the U.S. Centers for Disease Control and Prevention (CDC) issued a similar statement last week during a press conference, linking the J&J injection to the phenomenon of deadly blood clots.
According to PRAC, the deadly blood clots are more than likely the result of an injected person's body triggering an autoimmune response. This response mirrors the reaction often seen in patients treated with the pharmaceutical drug heparin, a blood-thinning agent.
Concerns about the AstraZeneca-Oxford injection causing deadly blood clots resulted in U.S. authorities halting the company's phase-three trial for more than a month.
Many now believe that the blood clot problem with both the AstraZeneca-Oxford jab and the J&J jab has to do with the fact that both of them are built upon an adenovirus platform. It is important to note, however, that even more deadly blood clots are occurring in people who receive the Chinese virus injections from Pfizer-BioNTech and Moderna, both of which are built upon a messenger RNA (mRNA) platform.
PRAC has indicated that it will soon make "further recommendations" concerning the safety of the J&J injection once it finishes accelerating its safety review. In the meantime, the J&J jab here in the United States will stay on hold.
"More and more cracks are appearing in the façade of the Great Reset as every article is now about faulty vaccines and infighting among regulatory agencies," wrote one commenter at Zero Hedge.
"But no warning on the mRNA vaccines that are much more deadly," commented another about the mysterious absence of regulatory concern about these jabs. "Strange."
To keep up with the latest news about injuries and deaths caused by Wuhan coronavirus (Covid-19) injections, be sure to check out ChemicalViolence.com.
Sources for this article include:
"Kama ilivyoelezwa hapo awali, ""kijaribio cha AstraZeneca-Oxford, ambacho pia husababisha kuganda kwa damu, ni chenye manufaa zaidi kuliko hatari.""" EMA imerudi nyuma kidogo kwa sababu ya chanjo ya J&J, ambayo pia ni hatari kwa sababu hiyo hiyo. "Hata ingawa hatari ya kupata ""mchanganyiko wa damu"" baada ya sindano hiyo inasemekana kuwa ""nadra sana,"" watu wengi sana wanakufa hivi kwamba serikali haiwezi tena kupuuza suala hilo au kujaribu kulificha chini ya zulia." "Kwa hivyo, mamlaka za afya zitakuwa ""kuweka alama"" kwa dawa za kulevya kama hatari na kutarajia watu bado kukubali kupewa." Hata hivyo, EMA haipangi kuweka lebo hiyo ya onyo kwenye chanjo ya AstraZeneca, labda kwa sababu hiyo imetengenezwa Ulaya na ile ya J&J imetengenezwa Marekani. Kamati ya usalama ya EMA, inayojulikana kama PRAC, iliamua kwamba kuganda kwa damu kunasababishwa na chanjo hutokea katika maeneo yasiyo ya kawaida kama vile katika mishipa ya ubongo (cerebral venous sinus thrombosis, CVST) na tumbo (splenchnic venous thrombosis), na pia katika mishipa. Kwa kawaida, kuganda kwa damu huko huambatana na kiwango cha chini cha vidonge vya damu na kutokwa na damu mara kwa mara. "Kamati hiyo iligundua kuwa athari hizo mbaya za maambukizi ni sawa na zile zinazotokea baada ya chanjo ya AstraZeneca na Oxford.""" Lakini tena, hiyo moja haijapunguzwa kwa sababu Ulaya inategemea hiyo ili kupata watu wengi katika bara hilo waliopigwa. "Kulingana na taarifa ya kamati hiyo, wataalamu wa afya na wengine wanaopokea chanjo hiyo ""wanapaswa kuwa na ufahamu wa uwezekano wa visa vichache sana vya kuganda kwa damu pamoja na viwango vya chini vya vidonge vya damu vinavyotokea ndani ya wiki tatu za chanjo.""" Afisa wa juu wa Kituo cha Kudhibiti na Kuzuia Magonjwa cha Marekani (CDC) alitoa taarifa kama hiyo wiki iliyopita wakati wa mkutano wa waandishi wa habari, akihusianisha sindano ya J&J na tukio la kuganda kwa damu. Kulingana na PRAC, kuganda kwa damu kunaweza kutokea kwa sababu mwili wa mtu aliyejiingiza dawa hiyo umesababisha majibu ya kinga ya mwili. Jibu hilo linafanana na lile linalopatikana mara nyingi kwa wagonjwa wanaotumiwa dawa ya heparin, ambayo hupunguza kiasi cha damu. Shughuli za AstraZeneca na Oxford za kutengeneza dawa za kulevya zimesababisha kutoelewana kwa watu na serikali ya Marekani imesababisha kampuni hiyo kusimamisha majaribio ya hatua ya tatu kwa zaidi ya mwezi mmoja. "Watu wengi sasa wanaamini kuwa tatizo la kuganda kwa damu na chanjo ya AstraZeneca-Oxford na chanjo ya J&J inahusiana na ukweli kwamba zote mbili zimejengwa juu ya jukwaa la adenovirus. """ Hata hivyo, ni muhimu kutambua kwamba hata kuganda kwa damu kwa hatari zaidi kunatokea kwa watu wanaopokea sindano za virusi vya Kichina kutoka kwa Pfizer-BioNTech na Moderna, zote mbili zikitengenezwa juu ya jukwaa la RNA ya mjumbe (mRNA). PRAC imeonyesha kuwa hivi karibuni itafanya mapendekezo zaidi kuhusu usalama wa sindano ya J&J mara tu itakapomaliza kuharakisha ukaguzi wake wa usalama. Wakati huo huo, chanjo ya J&J hapa Marekani itabaki kusimamishwa. "Mavunjiko zaidi na zaidi yanaonekana kwenye uso wa Reset Kubwa kwani kila makala sasa inahusu chanjo zenye kasoro na mapigano ya ndani kati ya mashirika ya udhibiti, ""aliandika mwandishi mmoja katika Zero Hedge." "Lakini hakuna onyo juu ya chanjo za mRNA ambazo ni hatari zaidi, ""alitoa maoni mengine juu ya ukosefu wa ajabu wa wasiwasi wa udhibiti juu ya chanjo hizi." "Ni jambo la ajabu". Kwa habari zaidi kuhusu majeraha na vifo vinavyosababishwa na sindano za coronavirus ya Wuhan (Covid-19), hakikisha angalia ChemicalViolence.com. Vyanzo vya makala hii ni pamoja na: